Transplantation combined with immunotherapy to cure liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherap ...

Since 2010, the NEXTY Awards have honored the highest quality natural products in the world. This year, Qualia Life Sciences ...

GLP-1 receptor agonists were associated with better graft and patient survival. Clinical trials are needed to confirm these findings.

In the last three years, Make-A-Wish Idaho, a nonprofit that grants wishes for children with critical illnesses, has seen ...

Cefiderocol exhibited clinical utility among a cohort of immunocompromised adult inpatients with MDR infections.

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA (pemivibart) against LP.8.1 Centers for Disease Control reports LP.8.1, XEC and KP.3.1.1 together constitu ...

Investors interested in arranging a meeting with the Company's management virtually during the conference should contact the ...

Seven lives have been saved thanks to a bumper week of emergency transplant activity at Royal Papworth Hospital NHS Foundation Trust.

The NHS could be about to start offering a vaccine - bringing it into line with Germany, Canada, Australia and the USA ...

Cytosorbents Corporation’s CTSO share price has surged by 14.00%, which has investors questioning if this is right time to ...

TEVIMBRA is a uniquely designed humanized immunoglobulin G4 (IgG4) anti-programmed cell death protein 1 (PD-1) monoclonal antibody with high affinity and binding specificity against PD-1. It is ...